ATHA

Athira Pharma, Inc. (ATHA) Risks & Opportunities Analysis (2026)

Invetso Score: 6.8/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 6.2 (Moderate)

Low leverage and strong liquidity reduce balance-sheet pressure, but limited interest coverage visibility can still constrain flexibility versus better-disclosed peers.

Negative cash conversion cycle supports working-capital efficiency, yet the absence of inventory and receivables data limits confidence versus more transparent peers.

Minimal debt-to-equity lowers refinancing risk, but peers with similarly light leverage and stronger earnings coverage may retain more optionality in downturns.

The current ratio is very strong, but if operating cash generation weakens, peers with diversified funding or recurring cash flows would be better insulated.

Opportunities

Score:

Very high current and quick ratios provide substantial liquidity headroom, supporting resilience versus peers with tighter near-term funding profiles.

Net debt to EBITDA below 1.0 suggests modest balance-sheet drag, which can preserve strategic flexibility relative to more levered peers.

Negative cash conversion cycle indicates efficient working-capital management, potentially allowing ATHA to fund growth with less external capital than peers.

Low debt intensity can help ATHA absorb cyclical demand softness better than peers with heavier fixed financial obligations.

Overall Score

Score:

ATHA’s strong liquidity, low leverage, and efficient working capital create meaningful upside versus peers, but limited earnings coverage visibility and disclosure constraints keep the risk profile only moderately favorable.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Athira Pharma, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →